Nanhui Liu

672 total citations
21 papers, 490 citations indexed

About

Nanhui Liu is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Nanhui Liu has authored 21 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Biotechnology. Recurrent topics in Nanhui Liu's work include Cancer Research and Treatments (7 papers), Immunotherapy and Immune Responses (7 papers) and Nanoplatforms for cancer theranostics (6 papers). Nanhui Liu is often cited by papers focused on Cancer Research and Treatments (7 papers), Immunotherapy and Immune Responses (7 papers) and Nanoplatforms for cancer theranostics (6 papers). Nanhui Liu collaborates with scholars based in China. Nanhui Liu's co-authors include Qian Chen, Zhuang Liu, Linfu Chen, Yang Yang, Maoyi Li, Jingjing Shen, Jiafei Zhu, Yumin Wu, Feng Pan and Muchao Chen and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Nanhui Liu

19 papers receiving 488 citations

Peers

Nanhui Liu
Luke J. Kubiatowicz United States
Keita Un Japan
Jingbo Ma China
Piper A. Rawding United States
Wenhao Li China
Nanhui Liu
Citations per year, relative to Nanhui Liu Nanhui Liu (= 1×) peers Qingling Song

Countries citing papers authored by Nanhui Liu

Since Specialization
Citations

This map shows the geographic impact of Nanhui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanhui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanhui Liu more than expected).

Fields of papers citing papers by Nanhui Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanhui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanhui Liu. The network helps show where Nanhui Liu may publish in the future.

Co-authorship network of co-authors of Nanhui Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Nanhui Liu. A scholar is included among the top collaborators of Nanhui Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanhui Liu. Nanhui Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lin, Xu Chen, Xiaojing Lu, et al.. (2025). Gambogic Acid Based Coordination Polymer Reinforces High‐Intensity Focused Ultrasound Treatment of Gynecologic Malignancies. Advanced Materials. 37(26). e2501664–e2501664. 2 indexed citations
2.
Pan, Feng, Qiang Zhang, Nanhui Liu, et al.. (2025). Inhalable Lipid Nanoparticles with Mucus Clearance and ROS Scavenging Properties for Acute Lung Injury Treatment. Advanced Functional Materials. 35(48).
3.
Zhang, Zhang, Jiafei Zhu, Nanhui Liu, et al.. (2025). Multifunctional microgel stent accelerates wound healing. Nano Research. 18(9). 94907719–94907719.
4.
Chen, Zhike, Yi Liu, Linfu Chen, et al.. (2025). A Noninvasive and Highly Effective Inhaled Nanovaccine Based on Natural Polysaccharide for Lung Cancer Treatment. Advanced Materials. 37(42). e04987–e04987. 1 indexed citations
5.
Wu, Yumin, Bo Liu, Yifan Yan, et al.. (2024). Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy. Nature Communications. 15(1). 10503–10503. 11 indexed citations
6.
Li, Maoyi, Nanhui Liu, Jiafei Zhu, et al.. (2024). Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Biomaterials. 309. 122584–122584. 41 indexed citations
7.
Shen, Jingjing, Linfu Chen, Xinying Lv, et al.. (2024). Emerging Co‐Assembled and Sustained Released Natural Medicinal Nanoparticles for Multitarget Therapy of Choroidal Neovascularization. Advanced Materials. 36(23). e2314095–e2314095. 24 indexed citations
8.
Zhang, Lin, Xiaoyan Gao, Yaru Sheng, et al.. (2024). pH‐Responsive and Therapeutic Liposomes for Enhanced High‐Intensity Focused Ultrasound Imaging and Therapy in Gynecologic Malignancies. Advanced Functional Materials. 35(5). 1 indexed citations
9.
Chen, Linfu, Jingjing Shen, Miao Yu, et al.. (2024). An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria. Science Bulletin. 69(16). 2565–2579. 33 indexed citations
11.
Cao, Zhiqin, Ting Wei, Jiafei Zhu, et al.. (2024). Minimalist Nanovaccine with Optimized Amphiphilic Copolymers for Cancer Immunotherapy. ACS Nano. 18(4). 3349–3361. 9 indexed citations
12.
Wang, Cheng, Linfu Chen, Jiafei Zhu, et al.. (2024). Programmable Bacteria‐Based Biohybrids as Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy. Advanced Functional Materials. 34(30). 19 indexed citations
13.
Chen, Linfu, Rui Zhao, Jingjing Shen, et al.. (2023). Antibacterial Fusobacterium nucleatum‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer. Advanced Materials. 35(45). e2306281–e2306281. 65 indexed citations
14.
Chen, Linfu, Lin Zhang, Rui Zhao, et al.. (2023). Oral delivery of anti-PD-L1 antibody for cancer immunotherapy against orthotopic colorectal tumors. Nano Today. 50. 101834–101834. 22 indexed citations
15.
Shen, Jingjing, Huiqin Gao, Linfu Chen, et al.. (2023). Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment. Science Advances. 9(4). eabq3104–eabq3104. 55 indexed citations
16.
Liu, Nanhui, Junjie Zhu, Wenjun Zhu, et al.. (2023). X‐ray‐Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy. Advanced Materials. 35(29). e2302220–e2302220. 77 indexed citations
17.
Chen, Linfu, Rui Zhao, Zhiqin Cao, et al.. (2023). Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. Journal of Controlled Release. 363. 43–56. 32 indexed citations
18.
Wu, Yumin, Chunjie Wang, Yifan Yan, et al.. (2023). Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits. ACS Nano. 17(18). 18089–18102. 22 indexed citations
19.
Cao, Zhiqin, Rui Zhao, Nanhui Liu, et al.. (2023). A coordinative dendrimer-based nanovaccine for cancer treatment. Matter. 6(10). 3574–3597. 19 indexed citations
20.
Xu, Lingling, Nanhui Liu, Wenjun Zhan, et al.. (2022). Granzyme B Turns Nanoparticle Fluorescence “On” for Imaging Cytotoxic T Lymphocyte Activity in Vivo. ACS Nano. 16(11). 19328–19334. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026